Engineering Chimeric Antigen Receptors

Chimeric antigen receptors (CARs) are recombinant protein molecules that redirect cytotoxic lymphocytes toward malignant and other target cells. The high feasibility of manufacturing CAR-modified lymphocytes for the therapy of cancer has spurred the development and optimization of new CAR T cells di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulemzin, S. V., Kuznetsova, V. V., Mamonkin, M., Taranin, A. V., Gorchakov, A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406655/
https://www.ncbi.nlm.nih.gov/pubmed/28461969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406655/
https://www.ncbi.nlm.nih.gov/pubmed/28461969

Ejemplares similares